TABLE 2.
Variables contributing to the variability observed in the virus neutralization test 1 year after infection
| Assay |
R² for:a |
|||
|---|---|---|---|---|
| Int100 | Slope30 | Both | Int100, slope30, and clinicalb | |
| VNT | 0.744 | 0.388 | 0.764 | 0.770 |
| Abb_S | 0.654 | 0.126 | 0.701 | 0.706 |
| Dia_S | 0.662 | 0.005 | 0.689 | 0.694 |
| Roc_S | 0.670 | 0.020 | 0.678 | 0.714 |
| Sie_S | 0.689 | 0.075 | 0.713 | 0.714 |
| Tec_N | 0.422 | 0.003 | 0.433 | 0.494 |
| Tec_S | 0.652 | 0.373 | 0.669 | 0.680 |
R2 values as a measure for the variability explained by the antibody level at 100 days after infection (int100), the slope of the antibody kinetics within 30 days (slope30), and a combination of both (R2 both).
The clinical baseline parameters of age, gender, WHO peak, immunodeficiency, and multimorbidity were additionally considered.